What You Should Know:
- Sonde Health, a Boston, MA-based health technology company committed to bringing accessible health monitoring to everyone raises $19.25 million in a Series B investment round led by Partners Investment, with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures.
- The AI vocal biomarker company will use the funding to accelerate its commercial growth, expand its platform into new health
Read More
patient stratification
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers
What You Should Know:
- NeuroSense Therapeutics Ltd., a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company developing objective and sensitive biomarkers for neurological disorders, today announced a collaboration to advance the science of digital biomarkers in the detection and monitoring of neurological diseases including amyotrophic lateral sclerosis (ALS).
- This agreement marks NeuraLight’s first clinical trial and comes on the heels of
Read More
Embright Taps Innovaccer to Advance Population Health Initiatives
What You Should Know:
-Clinically integrated network (CIN) Embright selects Innovaccer to advance population health initiatives across its network.
- The clinically integrated network will leverage Innovaccer’s Data Activation Platform to track its overall performance and address patient healthcare needs.
Innovaccer, Inc., a healthcare technology company, today announced it has partnered with Embright, a Pacific Northwest-based clinically integrated network (CIN) founded by UW
Read More
Innovaccer Launches Perioperative Optimization Platform for Surgeons
What You Should Know:
- Innovaccer launches a perioperative
optimization solution for surgeons to realize clinical and financial goals with
patient-risk analysis.
- The solution redefines surgical planning and
post-surgical recovery with machine learning-based patient stratification for
optimized surgery experience and personalized patient care management.
Innovaccer, Inc., a San Francisco, CA-based healthcare technology company, recently launched its perioperative optimization
Read More
TeraRecon Acquired by SymphonyAI: What is the Impact for Medical Imaging Market?
On the 4th March 2020, TeraRecon announced it had signed an agreement to be acquired by the SymphonyAI Group. Here are the facts of the deal, followed by our take on the potential impact on the medical imaging market:
- The terms of the deal were not disclosed and TeraRecon will continue to operate business as usual. However, it will benefit from greater financial backing and the synergistic technologies from other companies in the Group’s portfolio.
- TeraRecon is an Advanced
Read More
The Many Faces of AI in Clinical Trials
AI is being applied in several aspects for the clinical trial process today. From analyzing real-world data and scientific information to providing improved patient stratification and predictive outcomes, and assisting with different aspects of clinical trial operations. Here are some of the technologies using AI and machine learning in the clinical trial space today, outlining how they fit within the clinical trial ecosystem and discuss the impact on future clinical trial designs.
The
Read More
Why SDoH Data Is Key For Developing Population Health Strategies
The healthcare industry has come a long way in its appreciation of non-clinical factors impacting a patient’s overall well-being, such as social determinants of health (SDoH).
However, the industry has made less progress when it comes to gathering information on individual patients’ social determinants, analyzing the details and – most importantly – translating the findings into actionable information that healthcare organizations (HCOs) can use to improve population health management.
One
Read More
Can Artifical Intelligence Solve The Chronic Kidney Disease Epidemic?
Chronic kidney disease (CKD) is a growing epidemic worldwide. Currently, there are 850 million individuals suffering from CKD globally, with 40 million in the United States alone. Of these individuals, 96 percent are not aware of having CKD, as kidney disease often exhibits no symptoms until it has progressed to a late stage.
As this epidemic continues to grow, healthcare providers and organizations are working to determine how artificial intelligence (AI) can be used to analyze electronic
Read More
3 Keys to Scaling Up Population Health Management for Providers
Financial incentives, technological advances and pioneering care models have provided fertile soil for the green shoots of population health to grow. But for these programs to flourish, they will need more sophisticated analytics, patient stratification, community involvement and care management.This week, PwC’s Health Research Institute (HRI) released “Population health: Scaling up,” where they interviewed executives in leading healthcare, research and academic institutions on how organizations
Read More
